Anticancer Effects of Huaier are Associated with Down-Regulation of P53

被引：3

作者：

Xu, Xiao ^{[1
]}

Wei, Qiang ^{[1
]}

Wang, Kai ^{[1
]}

Ling, Qi ^{[1
]}

Xie, Haiyang ^{[1
]}

Zhou, Lin ^{[1
]}

Zheng, Shusen ^{[1
]}

机构：

[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China

来源：

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION | 2011年 / 12卷 / 09期

关键词：

Huaier; hepatocellular carcinoma; anticancer effect; animal model; NITROSODIETHYLAMINE INDUCED HEPATOCARCINOGENESIS; HEPATOCELLULAR-CARCINOMA; ALPHA-FETOPROTEIN; GALLIC ACID; RATS; DAMAGE; DNA; DIETHYLNITROSAMINE; RECURRENCE; SILYMARIN;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This study was designed to explore the mechanism of Huaier anticancer effects on experimental hepatocellular cancer (HCC) development. Seventy five rats were divided into 5 groups, administered N-nitrosodiethylamine (groups B, C, D and E) or natural saline (group A). Rats in group C and E were also given Huaier. At the 15 week sacrifice point, the HCC incidence of group C was lower than group correlating with serum AFP. The serum ALT concentration (98.9% greater) and P53 mRNA levels (23.2%) were higher in Group B than group C. Longer term survival rates between group D and E were not significantly different. Huaier can protect liver from chemical injury and furthermore HCC development, possibly with involvement of down-regulation of P53.

引用

页码：2251 / 2254

页数：4

共 50 条

[31] Down-regulation of Wilms’ tumor 1 expression in glioblastoma cells increases radiosensitivity independently of p53
Aaron J. Clark
Dana C. Chan
Mike Y. Chen
Helen Fillmore
Wagner G. Dos Santos
Timothy E. Van Meter
Martin R. Graf
William C. Broaddus
Journal of Neuro-Oncology, 2007, 83 : 163 - 172
[32] Cyclin A promoter activity and its down-regulation by normal p53 in human hepatoma cell lines
Kokuno, S
Magami, Y
Furukawa, M
Tukioka, Y
Nakayama, D
Saito, T
NIkaido, T
GASTROENTEROLOGY, 1999, 116 (04) : A441 - A441
[33] Attenuation of p53 expression and Bax down-regulation during phorbol ester mediated inhibition of apoptosis
Messmer, UK
Brune, B
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (04) : 625 - 634
[34] Chronic treatment of human fibroblasts cultures with diacylglycerol induces down-regulation of p53 functional activity
Magnelli, L
Cinelli, M
Chiarugi, V
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (01) : 222 - 225
[35] FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression
Lloreta, Josep
Font-Tello, Alba
Juanpere, Nuria
Frances, Albert
Lorenzo, Marta
Nonell, Lara
de Muga, Silvia
Vazquez, Ivonne
Cecchini, Lluis
Hernandez-Llodra, Silvia
HUMAN PATHOLOGY, 2017, 62 : 222 - 231
[36] Paris saponin I induce toxicity in zebrafish by up-regulation of p53 pathway and down-regulation of wnt pathway
Ni, Boran
Wang, Wenping
Liu, Manting
Xu, Yuchen
Zhao, Jinxi
TOXICON, 2023, 228
[37] Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage
Joseph, TW
Zaika, A
Moll, UM
FASEB JOURNAL, 2003, 17 (12): : 1622 - 1630
[38] Onset of Quiescence Following p53 Mediated Down-Regulation of H2AX in Normal Cells
Atsumi, Yuko
Fujimori, Hiroaki
Fukuda, Hirokazu
Inase, Aki
Shinohe, Keitaro
Yoshioka, Yoshiko
Shikanai, Mima
Ichijima, Yosuke
Unno, Junya
Mizutani, Shuki
Tsuchiya, Naoto
Hippo, Yoshitaka
Nakagama, Hitoshi
Masutani, Mitsuko
Teraoka, Hirobumi
Yoshioka, Ken-ichi
PLOS ONE, 2011, 6 (08):
[39] Down-regulation of TFAM increases the sensitivity of tumour cells to radiation via p53/TIGAR signalling pathway
Jiang, Xu
Wang, Jun
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (07) : 4545 - 4558
[40] p53 tumor suppressor protein content in human uterine leiomyomas and its down-regulation by 17β-estradiol
Gao, ZJ
Matsuo, H
Nakago, S
Kurachi, O
Maruo, T
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08): : 3915 - 3920

← 1 2 3 4 5 →